At a glance

ClinicalIndex Comparison Record

N/ACompleted· 100 enrolled

Drug / intervention

FAM 3D map group +1 moreprocedure

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03350581

NCT03350581N/ACompleted

Compare CT.gov

Does the Merged 3D Imaging Improve Contact Force and Long Term Procedure Outcome in Atrial Fibrillation? (MICRO-AF Study)

Korea University Guro Hospital·interventional·Posted Nov 22, 2017·Updated Dec 3, 2019

In Brief

A clinical study evaluating FAM 3D map group and FAM-CT 3D map group for Atrial Fibrillation. Completed, enrolled 100 participants across 2 sites.

Detailed Summary

The purpose of the study is to investigate whether or not there are the differences in acute procedure and long-term clinical outcome of radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) using the 3D map constructed by the integration of CT(or MRI) with the fast anatomical mapping (FAM) versus using the 3D map constructed by FAM only.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsAtrial Fibrillation

CountriesSouth Korea

CollaboratorsJohnson & Johnson

Timeline

N/ACompletedFinished

201820192020202120222023202420252026

Enrollment StartNov 2017

First PostedNov 2017

Primary CompletionAug 2019

Study CompletionNov 2019

TodayJul 2026

First PostedNov 22, 2017

Enrollment StartNov 21, 2017

Primary CompletionAug 20, 2019

Study CompletionNov 30, 2019

TodayJul 2, 2026

Enrollment to primary: 1.7 yearsPosted 8.6 years ago

Interventions

FAM 3D map groupprocedure

Radiofrequency catheter ablation using the 3D map which is constructed by FAM alone.

FAM-CT 3D map groupprocedure

Radiofrequency catheter ablation using the 3D map which is constructed by the integration of the FAM with CT or MRI.